Table: Stella Pharma - 6-MTH parent results

Stella Pharma

09/11/2023 06:20

Nov 9 (Reuters)- 
             Stella Pharma Corporation 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2023        Sep 30, 2022      Mar 31, 2024  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            153 mln             92 mln            269 mln    
                 (+66.7 pct)         (+33.3 pct)       (+17.4 pct)  
  Operating     loss 301 mln        loss 366 mln        loss 1.31   
  Recurring     loss 303 mln        loss 342 mln        loss 1.31   
  Net           loss 305 mln        loss 344 mln        loss 1.33   
  EPS           loss 9.95 yen      loss 12.00 yen    loss 44.28 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T